Aethlon Medical Inc EV/EBIT
What is the EV/EBIT of Aethlon Medical Inc?
The EV/EBIT of Aethlon Medical Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Industrials sector on NASDAQ compared to Aethlon Medical Inc
What does Aethlon Medical Inc do?
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
Companies with ev/ebit similar to Aethlon Medical Inc
- Central African Gold has EV/EBIT of N/A
- AmWolf Capital has EV/EBIT of N/A
- Societa Editoriale Il Fatto S.p.A has EV/EBIT of N/A
- Aspira Women's Health has EV/EBIT of N/A
- Eurolife Brands has EV/EBIT of N/A
- The Alkaline Water has EV/EBIT of N/A
- Aethlon Medical Inc has EV/EBIT of N/A
- Polo Resources has EV/EBIT of N/A
- Taysha Gene Therapies has EV/EBIT of N/A
- Universal Ibogaine has EV/EBIT of N/A
- Powerlong Coml Mgmt Hldg Ltd has EV/EBIT of N/A
- Purple Innovation Inc has EV/EBIT of N/A
- Oncopeptides AB (publ) has EV/EBIT of N/A